United States $20 Bn Breast Cancer Drug Market to 2025: 42 Marketed Drugs, 317 Drugs in Clinical Pipeline by Company, Phase, Drug Class & Patient Segment - P&T Community https://t.co/PR99bjlyDR
— IDRO (@IDROOhio) May 22, 2019
from Twitter https://twitter.com/IDROOhio
May 22, 2019 at 04:02AM
No comments:
Post a Comment